Live Quote · NASDAQUPBHealthcare· Biotechnology

Upstream Bio, Inc.

$1.59▼ 20.50%($-0.41)
MKT CAP $87.15MNEXT EARNINGS Mar 17, 2027
50%
Bullish
TickerSpark Score
53/100
▌ Mixed
60
Valuation
40
Profitability
50
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UPB research report →

Analyst Price Target
$25.00+1472.3% vs. today

Range $25 – $25

Analyst RatingBuy
3 Buy2 Hold0 Sell

Price Chart

-93.63% · this period
$32.60$17.10$1.59Nov 20May 26Nov 20
52-Week Range0% of range
Low
$1.56
Current
$1.59
High
$33.68